Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Off-label prescriptions for GLP-1s became far more common as the study went on, jumping 15-fold between 2021 and 2025.
Simplified Text
Off-label prescriptions for GLP-1 drugs increased 15-fold between 2021 and 2025.
Confidence Score
1.000
Claim Maker
The New York Times
Context Type
News Article
Context Details
{
    "date_range": "2021-2025",
    "increase_factor": "15-fold",
    "prescription_type": "off-label"
}
Subject Tags
Statistics GLP-1 Prescriptions Off-label Use
UUID
b878524f-8581-4c19-8463-0f7b0a3ce12b
Vector Index
✗ No vector
Created
September 25, 2026 at 10:06 AM (2 weeks ago)
Last Updated
September 25, 2026 at 10:06 AM (2 weeks ago)

Original Sources for this Claim (3)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html
GLP-1 Prescriptions for People With No Medical Need Are Climbing
Completed News
7 claims
2 weeks ago
https://nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html

A new study analyzing over 92 million U.S. adult medical records found more than 1.1 million people taking GLP-1 medications without an apparent medical reason like obesity or diabetes. Doctors express concern over off-label use, potential risks, and the cultural phenomenon surrounding these drugs.

GLP-1 drugs Ozempic Off-label prescriptions Weight loss drugs Medical ethics Public health Obesity Diabetes
Screenshot of https://nytimes.com/2026/09/14/dining/chefs-dining-beverage-trends.html
We Asked Chefs What They Think of You. Here’s What They Said.
Completed Analysis
19 claims 🔥
2 weeks ago
https://nytimes.com/2026/09/14/dining/chefs-dining-beverage-trends.html

A dozen chefs from the 2026 edition of a '50 favorite restaurants' list share their observations on current dining habits. Topics include the impact of GLP-1s, changing drinking preferences, the rise of early reservations, the role of social media influencers, and the potential of AI in the restaurant industry.

Dining Trends Restaurant Industry Chef Perspectives GLP-1s Non-Alcoholic Beverages Social Media Influencers Artificial Intelligence Early Reservations
Screenshot of https://nytimes.com/2026/09/21/us/politics/jb-pritzker-glp-1-ozempic-2028-presidential-race.html
Sizing Up a 2028 Bid, He Used a Weight-Loss Drug to Drop 80 Pounds
Completed News
11 claims 🔥
1 week ago
https://nytimes.com/2026/09/21/us/politics/jb-pritzker-glp-1-ozempic-2028-presidential-race.html

Illinois Gov. JB Pritzker, a potential 2028 presidential candidate, revealed on "CBS Mornings" he lost 80 pounds using a GLP-1 regimen since 2024. This disclosure comes as he deflects presidential ambitions while running for re-election as governor.

JB Pritzker GLP-1 Weight Loss 2028 Presidential Race Illinois Politics Democratic Party

Similar Claims (5)

Other claims identified as semantically similar to this one.